Ernexa Therapeutics Inc. (ERNA) › Net IncomeErnexa Therapeutics Inc. (ERNA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2010: -$400.0K2011: -$3.42M2012: -$995.0K2013: -$1.05M2014: -$5.03M2015: -$7.23M2016: -$2.92M2017: -$1.08M2018: -$259.0K2019: -$2.05M2020: -$7.29M2021: -$122.55M2022: -$24.58M2023: -$21.67M2024: -$44.54M2025: -$14.08M-$14.08M2010Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$14.08M+68.4%2024-$44.54M-105.6%2023-$21.67M+11.8%2022-$24.58M+79.9%2021-$122.55M-1580.8%2020-$7.29M-256.2%2019-$2.05M-690.3%2018-$259.0K+76.0%2017-$1.08M+63.2%2016-$2.92M+59.5%2015-$7.23M-43.7%2014-$5.03M-377.7%2013-$1.05M-5.8%2012-$995.0K+70.9%2011-$3.42M-754.8%2010-$400.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share